← FDA Drug Approvals (Drugs@FDA)
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2016-11-03
Drug application
- FDA Application #
ANDA202491- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- Generic name
- OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2016-11-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown